$MRK News Article - U.S. FDA Accepts for Priority Review the Supplemental New Drug Application for Merck's PREVYMIS(TM) for Prophylaxis of Cytomegalovirus Disease in Kidney Transplant Recipients at High Risk
https://marketwirenews.com/news-releases/u-s-...54726.html